Correction to: Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-2000
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Correction to: Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants ; volume:24 ; number:4 ; day:22 ; month:6 ; year:2020 ; pages:505 ; date:8.2020
Molecular diagnosis & therapy ; 24, Heft 4 (22.6.2020), 505, 8.2020
- Urheber
-
Pestinger, Valerie
Smith, Matthew
Sillo, Toju
Findlay, John M.
Laes, Jean‑Francois
Martin, Gerald
Middleton, Gary
Taniere, Phillipe
Beggs, Andrew D.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40291-020-00479-2
- URN
-
urn:nbn:de:101:1-2020091119554743125999
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pestinger, Valerie
- Smith, Matthew
- Sillo, Toju
- Findlay, John M.
- Laes, Jean‑Francois
- Martin, Gerald
- Middleton, Gary
- Taniere, Phillipe
- Beggs, Andrew D.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants
Mutational landscape of pan-cancer patients with PIK3CA alterations in Chinese population
SWI/SNF complex gene variations are associated with a higher tumor mutational burden and a better response to immune checkpoint inhibitor treatment: a pan-cancer analysis of next-generation sequencing data corresponding to 4591 cases
Comprehensive assessment of actionable genomic alterations in primary colorectal carcinoma using targeted next-generation sequencing
Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach
Mutational and non mutational adaptation of Salmonella enterica to the gall bladder
Detection of large rearrangements in a hereditary pan-cancer panel using next-generation sequencing
Applying machine learning to dervive actionable insights in precision oncology
Applying machine learning to derive actionable insights in precision oncology
Next-Generation Sequencing Analysis of Cell-Free DNA Identifies Actionable Alterations and Genomic Features in Pediatric Cancers
Machine actionable metadata models
Next-generation sequencing-based clinical diagnosis of choroideremia and comprehensive mutational and clinical analyses
Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants
Mutational landscape of pan-cancer patients with PIK3CA alterations in Chinese population
SWI/SNF complex gene variations are associated with a higher tumor mutational burden and a better response to immune checkpoint inhibitor treatment: a pan-cancer analysis of next-generation sequencing data corresponding to 4591 cases
Comprehensive assessment of actionable genomic alterations in primary colorectal carcinoma using targeted next-generation sequencing
Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach
Mutational and non mutational adaptation of Salmonella enterica to the gall bladder
Detection of large rearrangements in a hereditary pan-cancer panel using next-generation sequencing
Applying machine learning to dervive actionable insights in precision oncology
Applying machine learning to derive actionable insights in precision oncology
Next-Generation Sequencing Analysis of Cell-Free DNA Identifies Actionable Alterations and Genomic Features in Pediatric Cancers
Machine actionable metadata models
Next-generation sequencing-based clinical diagnosis of choroideremia and comprehensive mutational and clinical analyses
Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants
Mutational landscape of pan-cancer patients with PIK3CA alterations in Chinese population
SWI/SNF complex gene variations are associated with a higher tumor mutational burden and a better response to immune checkpoint inhibitor treatment: a pan-cancer analysis of next-generation sequencing data corresponding to 4591 cases
Comprehensive assessment of actionable genomic alterations in primary colorectal carcinoma using targeted next-generation sequencing
Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach
Mutational and non mutational adaptation of Salmonella enterica to the gall bladder
Detection of large rearrangements in a hereditary pan-cancer panel using next-generation sequencing
Applying machine learning to dervive actionable insights in precision oncology
Applying machine learning to derive actionable insights in precision oncology
Next-Generation Sequencing Analysis of Cell-Free DNA Identifies Actionable Alterations and Genomic Features in Pediatric Cancers
Machine actionable metadata models